<DOC>
	<DOC>NCT01631305</DOC>
	<brief_summary>The purpose of this study is to determine whether levothyroxine is effective and safe in the treatment of children with euthyroid sick syndrome, hospitalized in a pediatric intensive care unit.</brief_summary>
	<brief_title>Levothyroxine for Children With Euthyroid Sick Syndrome</brief_title>
	<detailed_description>Children with euthyroid sick syndrome, hospitalized in a pediatric intensive care unit, will be randomised to receive either Levothyroxine or placebo, to determine if it diminishes mortality.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Euthyroid Sick Syndromes</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<criteria>All children aged 1 month to 17 years. Admitted to pediatric intensive care unit. TSH and thyroid hormones below age specific levels. Known thyroid condition. Brain death. Gut conditions that contraindicate oral route. Readmissions to intensive care unit.</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Euthyroid Sick Syndromes</keyword>
	<keyword>Thyroxine</keyword>
	<keyword>Intensive care</keyword>
</DOC>